Drew Mendoza, MDMy most important study from #AHA2022: STRONG-HF
Not ground breaking, but more evidence.
Rapidly up titrate that #GDMT in #heartfailure
Huge improvement in readmissions and all-cause mortality!
Scott Auerbach MD 
Team dinner at #aha2022; so fortunate to be a part of this team. I feel like I am the ball boy for the dream team of pediatric heart failure and transplant here.
AnticoagPharmDHad a great time presenting at #AHA2022. Excited to have the opportunity to promote Anticoagulation Stewardship and the important work that Anticoagulation Specialists are doing to keep you safe as more and more patients switch to DOACs.
Tejas Patel MD No win for supplements…fish oil, cinnamon, garlic, turmeric, plant sterols or red yeast rice!!!
#AHA22 #AHA2022 https://www.jacc.org/doi/10.1016/j.jacc.2022.10.013
#AHA22 #AHA2022 https://www.jacc.org/doi/10.1016/j.jacc.2022.10.013
Dr. Ahmed’s @PHTSociety limited data set analysis showed that Fontan patients have a ~5-fold higher risk of post-operative dialysis compared to cardiomyopathy patients despite normal eGFR. #aha2022 @mgoschu @KSimpsonMD @marcrichmond1 @kdaly00
eGFR drops dramatically in the 1st week after repeat heart transplant in children and young adults, but rises above baseline at 1 year post repeat transplant. #AHA2022
On my way to #AHA2022
